Javier J. Benitez

Javier J. Benitez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 363 publications

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Journal: Nature communications

Published: September 09, 2025

Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Journal: Nature genetics

Published: September 26, 2023

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.

Journal: Breast cancer research : BCR

Published: April 05, 2023

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.

Journal: The journal of pathology. Clinical research

Published: November 23, 2022

FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.

FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.

Journal: European journal of human genetics : EJHG

Published: July 15, 2022

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

Journal: American journal of human genetics

Published: July 13, 2022

Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Journal: Nature genetics

Published: June 17, 2022

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

Journal: Cancer

Published: June 17, 2022

Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.

Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.

Journal: Genome medicine

Published: May 05, 2022

Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

Journal: European journal of human genetics : EJHG

Published: March 22, 2022

OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells.

OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells.

Journal: Frontiers in oncology

Published: March 03, 2022

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.

Journal: JAMA oncology

Published: January 27, 2022

Showing 1-12 of 363

Last Updated: 09/26/2026